Aller au contenu principal
Medicines or Food Supplements: How to Avoid the Pitfalls of Real Estate Commercialisation?
Droit-immobilier

Medicines or Food Supplements: How to Avoid the Pitfalls of Real Estate Commercialisation?

📅 Decision of 19 May 2009🔄 Updated on 14 October 2026⚖️ Cour de cassation👁️ 14 views📖 9 min read

The Court of Cassation reiterates the strict criteria for distinguishing between medicines and food supplements. This decision directly impacts real estate professionals who market products in their residences or commercial premises. Understanding this distinction can help avoid criminal prosecution.

Reference Decision: cc • No. 08-83.747 • 2009-05-19 • Consult the decision →

Imagine you own a shop in Dax, in the thermal district. You wish to diversify your income by offering for sale products based on local plants, such as those famous pine extracts from the Landes region whose virtues are praised. But here's the catch: are these products simply food supplements or medicines requiring specific authorisation? The question is not trivial, as the answer determines your entire liability.

In the commercial streets of Mimizan, how many shops today offer 'natural' products with enticing health promises? And how many landlord-lessors are unaware that the nature of products sold by their tenants can implicate their own liability? This blurred boundary between food supplement and medicine is at the heart of a major decision by the Court of Cassation.

The judgment of 19 May 2009 forcefully reminds us that this distinction is not a mere administrative formality. It implicates consumer safety and the legality of commercial activities. For property owners, tenants, and real estate professionals, understanding this case law is essential to avoid costly disputes. But what exactly does this change for your daily activities?

The Facts: A Story That Happens Every Day

The story begins with Mr Bernard, director of a company specialising in the commercialisation of products based on natural extracts. Established in a commercial zone in the Mont-de-Marsan region, he has been offering for several years various products composed of cartilage extracts and medicinal plants listed in the pharmacopoeia (official list of medicinal substances). These products are sold as food supplements, without requiring medical prescription.

The problem? Mr Bernard is not a pharmacist. However, if it turns out that his products are actually medicines, their commercialisation by an unqualified person constitutes a criminal offence. The health authorities, alerted by reports, initiate prosecution. They consider that these products, by their composition and the claims accompanying them, meet the legal definition of a medicine.

At first instance, the court acquits Mr Bernard. The judges consider that the products are indeed food supplements. But the public prosecutor appeals, considering that the qualification was not correctly analysed. The court of appeal confirms the acquittal, but its decision will be quashed by the Court of Cassation. Why? Because the magistrates did not sufficiently justify their decision. They did not examine all the legal criteria for distinguishing between medicine and food supplement.

undefined, I have encountered cases where owners of commercial premises in Dax found themselves involved in similar proceedings, simply because their tenants sold products with unclear regulatory boundaries. Mr Bernard's story is therefore not isolated: it illustrates a very real risk for all actors in the real estate sector.

The Court's Reasoning — Analysed

The Court of Cassation, in its judgment of 19 May 2009, reiterates a rigorous methodology for qualifying a product. The judges criticise the court of appeal for having too quickly dismissed the qualification as medicine without having conducted the complete analysis required by law. In short, the lower court judges did not complete their investigative work thoroughly.

The legal basis rests on Articles L. 4211-1 and L. 5111-1 of the French Public Health Code. Article L. 4211-1 defines a medicine as 'any substance or composition presented as possessing curative or preventive properties with respect to human diseases'. Article L. 5111-1, meanwhile, concerns medicines by function, i.e., those that act on the human body. In other words, a product can be qualified as a medicine either by its presentation (what is said about it) or by its function (what it does).

The Court of Cassation requires a case-by-case analysis, taking into account all the characteristics of each product. This includes: its exact composition, its pharmacological (effects on the body), immunological or metabolic properties established scientifically, its modes of use, the extent of its distribution, consumers' knowledge of it, and potential health risks. It is a complete checklist that every judge must go through.

The crucial point: when a product can be considered both a medicine and a food supplement (defined by the decree of 20 March 2006 as having nutritional or physiological properties), the doubt must benefit the qualification as medicine. This precautionary principle aims to protect public health. The court of appeal failed in this obligation by not verifying whether the products were presented as having curative properties, and by not examining each product individually.

This reasoning represents a confirmation of prior case law, but with particular emphasis on the rigour of the analysis. Mr Bernard's arguments (invoking the natural character of the products) were not sufficient to dismiss the qualification as medicine. The Court thus reminds us that the natural origin of a substance does not automatically exempt it from the medicine regime.

What This Changes for You — Practically

For landlord-lessors, this decision is a warning signal. If you lease a commercial premises in Mimizan to a tenant who sells natural products, you must ensure that these products are correctly qualified. In case of health inspection and erroneous qualification, your tenant risks criminal prosecution, and you could be held civilly liable if the lease includes guarantee clauses. Imagine a product sold as a food supplement in a shop on the seafront, but later qualified as a medicine: the financial consequences can be heavy.

For commercial tenants, vigilance is required. Commercialising a product as a medicine without authorisation exposes one to penalties of up to 2 years' imprisonment and a €75,000 fine (Article L. 4211-6 of the French Public Health Code). If you are in this situation, you must imperatively verify the qualification of each product with a regulatory expert before market placement. Verification delays can take several weeks, but it is a necessary investment.

For purchasers of business assets, this case law adds an additional due diligence (preliminary verification). Before buying a shop specialising in natural products in Dax, demand a complete regulatory audit of the products sold. A defect in qualification can lead to nullity of the sale or compensation. In a recent case, a purchaser discovered after the purchase that 30% of the business's products were actually unauthorised medicines, resulting in a loss of value of €50,000.

For co-owners of shopping centres, the management of commercial activities must integrate this risk. The co-ownership regulations can include clauses prohibiting the sale of products on the medicine/food supplement boundary without prior authorisation. Be careful, however: these clauses must be proportionate and not unduly hinder freedom of commerce.

Four Tips to Avoid This Type of Dispute

  • Systematically verify product qualification: Before leasing premises to a trader who sells natural products, require a certificate from a regulatory expert certifying that each product is indeed a food supplement and not a medicine. This document must be updated annually.
  • Include protective clauses in your leases: Insert a specific clause in the commercial lease obliging the tenant to comply with medicine regulations and to assume all financial and criminal consequences in case of breach. Providing a financial guarantee (deposit or insurance) can be wise.
  • Raise awareness among your tenants about risks: Organise an information meeting with your commercial tenants to explain the criteria for distinguishing between medicines and food supplements. Active prevention significantly reduces the risk of disputes.
  • Document all exchanges on the subject: Carefully preserve all written exchanges (emails, letters) with your tenants regarding the nature of products sold. In case of dispute, this documentation will be crucial to establish your good faith and diligence.

This decision fits into a consistent line of case law. Already in 2003, the Court of Cassation (judgment no. 01-85.678) had reiterated that the qualification of medicine must be examined with rigour, particularly for plant-based products. The trend of the courts is clear: faced with the development of the natural products market, judges are tightening their control to protect public health.

A prior divergent decision could have created confusion. In 2005, a court of appeal had acquitted a trader by considering that similar products were food supplements without thorough analysis. The 2009 judgment corrects this overly lax approach. What few people know is that this evolution corresponds to a 2004 European directive strengthening the regulation of herbal medicines.

For the future, this case law means that controls will multiply. Health authorities, particularly in tourist regions like the Landes where local products are valued, will increase their vigilance. Real estate professionals should expect more frequent inspections in shops selling natural products. How to react? By anticipating and strictly complying with regulations.

In Practice: What to Do

Here is a numbered checklist to guide you:

1. If you are a landlord-lessor: Before signing a lease with a trader of natural products, require a complete file including exact product compositions, their marketing authorisations, and an expert certificate. Particularly verify health claims on packaging and advertisements.

2. If you are a commercial tenant: Consult an expert in health product regulations before commercialising any new product. Maintain an up-to-date register of all your verifications. Train your staff on the limits of what can be said to customers regarding product effects.

3. If you are in ongoing dispute: Do not attempt to settle a dispute on product qualification alone. Immediately call upon a lawyer specialised in health law and real estate law. Prescription periods are short (generally 3 years), act quickly.

4. If you are considering a business asset sale: Include in the sale deed a specific guarantee clause concerning the regulatory qualification of products. Have an independent audit conducted whose conclusions will be annexed to the deed.

5. If you are a co-owner of a shopping centre: Propose at the general meeting the adoption of a resolution creating a commission to control commercial activities, including a section on compliance of products sold.

Do you find yourself in a similar situation? A first 30-minute consultation with Maître Zakine (€45) can save you months of proceedings — and often much more. Book an appointment →

📌 Does this apply to your situation? Maître Cécile Zakine, lawyer in French real estate law, practises throughout France.
→ Avocat bail commercial & droit immobilier  |  → Browse all our legal articles

Legal information

  • Number: 08-83.747
  • Court: Cour de cassation
  • Decision of: 19 May 2009

Keywords

médicamentcomplément alimentairedroit immobilierbail commercialresponsabilité

Practical use cases

1

Landlord in Nice discovers tenant's illegal supplement sales

A property owner in Nice (French Riviera) rents a commercial space to a tenant who sells 'natural energy boosters' containing ginseng and guarana extracts. After 8 months, health authorities fine the tenant €15,000 for illegally selling unapproved medicines. The landlord receives a formal notice about potential liability for allowing illegal activity on their property.

Practical application:

This case law applies because the Court of Cassation clarified that selling products as food supplements when they legally qualify as medicines creates liability risks for property owners. The landlord should immediately review the tenant's business license and product documentation to verify compliance. They must request official classification documents from health authorities (ANSM) for all products sold. If violations exist, they should issue a formal notice to the tenant to cease illegal sales or risk lease termination to avoid being held liable.

2

First-time buyer in Lyon inherits problematic commercial lease

A young professional buys a mixed-use property in Lyon (Presqu'île district) for €350,000, inheriting an existing tenant who sells 'detox teas' with bold health claims. Six months later, the tenant faces criminal prosecution for selling unauthorized medicines. The new owner worries about property value impact and potential legal complications.

Practical application:

This case law applies because the distinction between food supplements and medicines directly affects commercial lease legality and property value. The buyer should immediately consult a notaire to review the lease's compliance clauses regarding tenant activities. They must require the tenant to provide official ANSM classification certificates for all products. If products are unapproved medicines, they should negotiate lease amendment to prohibit such sales or consider legal action to protect their investment from devaluation due to illegal activities.

3

Co-owner in Paris disputes neighbor's herbal remedy shop

In a Paris (Marais district) co-owned building, one commercial unit owner operates a shop selling 'immune-support blends' with echinacea and elderberry. Other co-owners complain after 3 months about increased foot traffic and potential legal risks. The shop owner claims they're just food supplements, but packaging makes therapeutic promises.

Practical application:

This case law applies because the Court of Cassation established that misclassified medical products create liability that can extend to co-owners through building regulations. The co-owners should collectively request the shop owner to provide official product classifications from French health authorities. They should review building regulations to ensure commercial activities comply with legal standards. If products are unapproved medicines, they should formally demand cessation through the syndic (building manager) and consider legal action to prevent collective liability for illegal commercial activities in their building.

Maître Cécile Zakine

About the author

Maître Cécile Zakine — Lawyer at the Alpes-Maritimes Bar, Doctor of Law. Every article in this magazine is based on the analysis of a real court decision, commented and put into perspective by Maître Zakine’s team.

Book an appointment →

Disclaimer: The analysis presented on this site is for informational purposes only and does not constitute personalised legal advice. For advice tailored to your situation, contact a qualified lawyer.

★★★★★4.9/5 — Google Reviews

Does this affect you?

Consult Maître Zakine — lawyer, Doctor of Law. Fast, clear answer.

Book a consultation →

🔒 Confidential · No obligation

📬 Get legal updates

One legal analysis per week, straight to your inbox. Free, no spam.

🔒 1-click unsubscribe · GDPR compliant

★★★★★4.9/5 — Avis Google

Maître Zakine, Doctor of Law

Phone and video consultations available — Fast appointments

Book an appointment
First consultation 30 minutes — €45

🔒 Confidentiel • Sans engagement • Réponse rapide